Virtual Library

Start Your Search

  • WCLC 2016

    17th World Conference on Lung Cancer

    Access to all presentations that occur during the 17th World Conference on Lung Cancer in Vienna, Austria

    Presentation Date(s):  
    • Dec 4 - 7, 2016
    • Total Presentations: 2466

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Presentations will be available 24 hours after their live presentation time

Filter Results:

Show Only Available Presentations

  • +

    SH01 - WCLC 2016 Scientific Highlights - Prevention, Biology, Pathology

    • Type: Scientific Highlights
    • Track: Epidemiology/Tobacco Control and Cessation/Prevention
    • Presentations: 3
    • Moderators:M. Filipits
    • Coordinates: 12/05/2016, 07:30 - 08:30, Hall C1
  • +

    SC04 - EGFR Tyrosine Kinase Inhibitors: A Model for Successful Drug Development

    • Type: Science Session
    • Track: Chemotherapy/Targeted Therapy/Immunotherapy
    • Presentations: 5
    • Moderators:S. Thongprasert
    • Coordinates: 12/05/2016, 11:00 - 12:30, Hall C7
  • +

    P1.02 - Poster Session with Presenters Present

    • Type: Poster Presenters Present
    • Track: Biology/Pathology
    • Presentations: 87
    • Coordinates: 12/05/2016, 14:30 - 15:45, Hall B (Poster Area)
    • +

      P1.02-047 - Effect of Dasatinib on EMT-Mediated-Mechanism of Resistance against EGFR Inhibitors in Lung Cancer Cells

      14:30 - 14:30  |  Author(s): Y. Sesumi

      • Abstract

      Loading...

  • +

    PL03 - Presidential Symposium

    • Type: Plenary
    • Track:
    • Presentations: 10
    • Moderators:D.P. Carbone
    • Coordinates: 12/06/2016, 08:35 - 10:25, Hall D (Plenary Hall)
  • +

    MA07 - ALK-ROS1 in Advanced NSCLC

    • Type: Mini Oral Session
    • Track: Advanced NSCLC
    • Presentations: 12
    • Moderators:N. Singh
    • Coordinates: 12/06/2016, 11:00 - 12:30, Lehar 1-2
    • +

      MA07.03 - Alectinib (ALC) versus Crizotinib (CRZ) in ALK-Positive Non-Small Cell Lung Cancer (ALK+ NSCLC): Primary Results from Phase III Study (J-ALEX)

      11:12 - 11:18  |  Author(s): Y.H. Kim

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P2.03a - Poster Session with Presenters Present

    • Type: Poster Presenters Present
    • Track: Advanced NSCLC
    • Presentations: 72
    • Coordinates: 12/06/2016, 14:30 - 15:45, Hall B (Poster Area)
    • +

      P2.03a-009 - Clinical Outcome of Node-Negative Oligometastatic Non-Small Cell Lung Cancer

      14:30 - 14:30  |  Author(s): M. Takeda

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P2.08 - Poster Session with Presenters Present

    • Type: Poster Presenters Present
    • Track: Patient Support and Advocacy Groups
    • Presentations: 15
    • Coordinates: 12/06/2016, 14:30 - 15:45, Hall B (Poster Area)
    • +

      P2.08-007 - Listen Advocate Voice - Web-Survey for the Japanese Model of Lung Cancer Advocacy by Society

      14:30 - 14:30  |  Author(s): T. Sawa

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    SC21 - Predictive Biomarkers for Outcome of Systemic Therapy in NSCLC

    • Type: Science Session
    • Track: Biology/Pathology
    • Presentations: 5
    • Moderators:K. Kerr
    • Coordinates: 12/06/2016, 16:00 - 17:30, Hall C7
  • +

    MA15 - Immunotherapy Prediction

    • Type: Mini Oral Session
    • Track: Chemotherapy/Targeted Therapy/Immunotherapy
    • Presentations: 12
    • Moderators:O. Arrieta
    • Coordinates: 12/07/2016, 14:20 - 15:50, Schubert 1
    • +

      MA15.11 - Acquired Resistance Mechanisms to EGFR Kinase Inhibitors Alter PD-L1 Expression Status in Lung Cancer

      15:32 - 15:38  |  Author(s): K. Suda

      • Abstract

      Loading...

  • +

    MA16 - Novel Strategies in Targeted Therapy

    • Type: Mini Oral Session
    • Track: Chemotherapy/Targeted Therapy/Immunotherapy
    • Presentations: 12
    • Moderators:G. Purkalne
    • Coordinates: 12/07/2016, 14:20 - 15:50, Strauss 2
    • +

      MA16.11 - CNS Response to Osimertinib in Patients with T790M-Positive Advanced NSCLC: Pooled Data from Two Phase II Trials

      15:26 - 15:32  |  Author(s): G. Goss

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.